Starpharma Holdings Ltd has released a press release.
SPL signs expanded DEP research agreement with US Biopharma
Filed with ASX ·
6ix hasn’t read this filing yet.
Starpharma Holdings Limited on 6ix
Story so far
Earlier from Starpharma
- SPL7013 in VIRALEZE virucidal against influenza A and B
- Quarterly Cashflow and Activities Report
- VIRALEZE to relaunch in the UK
- Application for quotation of securities - SPL
- SPL7013 in VIRALEZE virucidal against Omicron
Later from Starpharma
- VIRALEZE relaunched by LloydsPharmacy in the UK
- VIRALEZE Protects Against Omicron in Viral Challenge Model
- Quarterly Activities Report & Appendix 4C
- Starpharma signs new DEP agreement with MSD
- Starpharma annual report and full year financial results
Follow Starpharma into a list and get an email when it puts out news.
Follow Starpharma